(27-02-13) Cancer breakthrough: Grape seed extract kills colorectal cancer cells

by Sherry Baker, Health Sciences Editor

(NaturalNews) Cancer researchers are working to find chemotherapies that
destroy cancer cells but are harmless to normal cells. It turns out, a natural
substance already exists that does just that. University of Colorado Cancer
Center scientists have just published a study in the journal Cancer Letters
that shows grape seed extract (GSE) is a powerful weapon against colorectal
cancer. It halts the growth and survival of colorectal cancer cells and kills
them in large numbers, too, while leaving healthy cells completely alone.

And the news about GSE gets better: the more advanced the colorectal cancer
cells, the more GSE shuts down the malignant cells' growth and survival. The
scientists think that GSE targets colorectal cancer by causing oxidative stress
that leads to the programmed cell death known as apoptosis.

"We've known for quite a while that the bioactive compounds in grape seed
extract selectively target many types of cancer cells. This study shows that
many of the same mutations that allow colorectal cancer cells to metastasize
and survive traditional therapies make them especially sensitive to treatment
with GSE," Molly Derry, doctoral candidate in the lab of Rajesh Agarwal, PhD,
investigator at the CU Cancer Center and professor at the Skaggs School of
Pharmacy and Pharmaceutical Sciences, said in a press statement.

Derry pointed out that the GSE findings are especially important due to the
increasing rates of colorectal cancer. Unfortunately, 60 percent of patients
diagnosed with this form of cancer have already reached the advanced stage of
the disease.

As the research team performed their experiments on colorectal cancer cell
lines representing all stages of the disease, they came up with another
startling finding. Although it usually takes much more chemotherapy to kill a
stage IV cancer cell than a stage II cancer cell, the exact opposite was true
when it came to grape seed extract.

"It required less than half the concentration of GSE to suppress cell growth
and kill 50 percent of stage IV cells than it did to achieve similar results in
the stage II cells," Derry revealed in a media statement.

"A colorectal cancer cell can have upwards of 11,000 genetic mutations --
differences from the DNA in healthy cells. Traditional chemotherapies may only
target a specific mutation and as cancer progresses more mutations occur. These
changes can result in cancer that is resistance to chemotherapy. In contrast,
the many bioactive compounds of GSE are able to target multiple mutations. The
more mutations a cancer presents, the more effective GSE is in targeting them,"
Derry added.

The Agarwal Lab studies the effectiveness and action of dietary compounds
against cancer and is encouraging further exploration of their findings in
clinical settings with patients. "Finding a way to selectively target advanced
colorectal cancer cells could have major clinical importance," Derry stated.

As NaturalNews previously reported, researchers from the University of
Kentucky have also conducted groundbreaking research into the anti-cancer
properties of grape seed extract. They found the natural substance triggered
the death of 76 percent of leukemia cells exposed to the extract in a
laboratory experiment. Their study, published Clinical Cancer Research, a
journal of the American Association for Cancer Research, showed that grape seed
extract triggered the destruction of leukemia cells by apparently "turning on"
a protein known as JNK that regulates the cancer cell killing pathway.

Sources:

http://www.cancerletters.info/article/S0304-3835(12)00732-X/abstract
http://www.coloradocancerblogs.org
http://www.naturalnews.com
http://www.sciencedirect.com/science/article/pii/S030438351200732X

News

---

In evidenza

"L'informazione presente nel sito serve a migliorare, e non a sostituire, il rapporto medico-paziente."

Per coloro che hanno problemi di salute si consiglia di consultare sempre il proprio medico curante.